Dr. Kevin Hay is an Associate Scientist at the Terry Fox Laboratory and Leukemia/Bone Marrow Transplant Program of BC in Vancouver. Dr. Hay received a Master of Science in Immunology at the University of Manitoba (2008), followed by an MD (2011). After completing residency in Internal Medicine (2014) and a clinical fellowship in Haematology (2016) at the University of British Columbia, he was awarded a scholarship through the Clinician Investigator Program of UBC to pursue a postdoctoral fellowship in cellular immunotherapy which he completed at the Fred Hutchinson Cancer Research Center in Seattle Washington under the mentorship of Dr. Cameron Turtle. Dr. Hay’s research focuses on understanding the unique toxicities associated with chimeric antigen receptor T (CAR-T) cells, as well as the development of novel CAR-T cell therapies.

Affiliations

Clinical Scientist, University of Calgary and Charbonneau Cancer Institute

Credentials

Professional Experience

Clinician Scientist, University of Calgary and Charbonneau Cancer Institute, 2023 - present

Associate Scientist, Terry Fox Laboratory, 2023 - present

Scientist, Terry Fox Laboratory, 2019 - 2023

Affiliate Associate Professor, Medicine, University of British Columbia (UBC), 2024 - present

Assistant Professor, Medicine, University of British Columbia (UBC), 2019 - 2023

Clinician Scientist, and Hematologist,
The Leukemia/Bone Marrow Transplant Program of BC, BC Cancer, 2019 - 2023

Medical Director, Clinical Cell Therapy, BC Cancer, 2019 - 2023

Medical Director, Conconi Family Immunotherapy Laboratory, BC Cancer, 2023 - present

Post-Graduate Training

Postdoctoral Research Fellow, Cellular Immunotherapy (Supervisor: Dr. Cameron Turtle),
Fred Hutchinson Cancer Research Center, 2016 – 2018

Clinical Investigator Program Fellow in Cellular Immunotherapy,
University of British Columbia, 2016 – 2018

Hematology Fellow, University of British Columbia, 2014 – 2014

Internal Medicine Resident, University of British Columbia, 2011 – 2014

Education

MD (Medicine), University of Manitoba, 2007 – 2011

MSc (Immunology), University of Manitoba, 2005 – 2008

BSc (Biology (Honors) and Chemistry),  Trinity Western University, 1999 – 2005

Selected Publications

Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22.

Molecular therapy. Oncology, 2024
McComb, Scott, Arbabi-Ghahroudi, Mehdi, Hay, Kevin A, Keller, Brian A, Faulkes, Sharlene, Rutherford, Michael, Nguyen, Tina, Shepherd, Alex, Wu, Cunle, Marcil, Anne, Aubry, Annie, Hussack, Greg, Pinto, Devanand M, Ryan, Shannon, Raphael, Shalini, van Faassen, Henk, Zafer, Ahmed, Zhu, Qin, Maclean, Susanne, Chattopadhyay, Anindita, Gurnani, Komal, Gilbert, Rénald, Gadoury, Christine, Iqbal, Umar, Fatehi, Dorothy, Jezierski, Anna, Huang, Jez, Pon, Robert A, Sigrist, Mhairi, Holt, Robert A, Nelson, Brad H, Atkins, Harold, Kekre, Natasha, Yung, Eric, Webb, John, Nielsen, Julie S, Weeratna, Risini D
Learn More

CLIC-01: Manufacture and distribution of non-cryopreserved CAR-T cells for patients with CD19 positive hematologic malignancies.

Frontiers in immunology, 2022
Kekre, Natasha, Hay, Kevin A, Webb, John R, Mallick, Ranjeeta, Balasundaram, Miruna, Sigrist, Mhairi K, Clement, Anne-Marie, Nielsen, Julie S, Quizi, Jennifer, Yung, Eric, Brown, Scott D, Dreolini, Lisa, Waller, Daniel D, Smazynski, Julian, Gierc, Nicole S, Loveless, Bianca C, Clark, Kayla, Dyer, Tyler, Hogg, Richard, McCormick, Leah, Gignac, Michael, Bell, Shanti, Chapman, D Maria, Bond, David, Yong, Siao, Fung, Rachel, Lockyer, Heather M, Hodgson, Victoria, Murphy, Catherine, Subramanian, Ana, Wiebe, Evelyn, Yoganathan, Piriya, Medynski, Liana, Vaillan, Dominique C, Black, Alice, McDiarmid, Sheryl, Kennah, Michael, Hamelin, Linda, Song, Kevin, Narayanan, Sujaatha, Rodrigo, Judith A, Dupont, Stefany, Hawrysh, Terry, Presseau, Justin, Thavorn, Kednapa, Lalu, Manoj M, Fergusson, Dean A, Bell, John C, Atkins, Harold, Nelson, Brad H, Holt, Robert A
Learn More
Back to top